dpp-4 inhibitors vs. glp-1 agonist Clinical Use of Were DPP-4 inhibitors the original
Description
Novel incretin analogues improve autophagy and protect from mitochondrial stress induced by rotenone in SH-SY5Y cells
Chang, C

The dataset used in this study was extensive, encompassing various aspects of patient information including demographic details, diagnoses (according to International Classification of Diseases, Tenth Revision, Clinical Modification [ICD-10-CM] codes), procedures (classified according to the International Classification of Diseases, Tenth Revision, Procedure Coding System [ICD-10-PCS] or Current Procedural Terminology), and medications (coded as per the Veterans Affairs National Formulary)

Martinez de Tejada Weber, Genve (Gyncologie-obsttrique)

The demand for GLP-1 receptor agonists is growing due to the favorable policies from various government institutions across the globe
